Kiho Chang

Title: Kiho Chang: Innovator in Cancer Treatment

Introduction

Kiho Chang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatment methods. His innovative work focuses on creating compounds that can effectively inhibit cancer cell proliferation.

Latest Patents

Kiho Chang holds a patent for a compound described as a 3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethinyl)-N-phenylbenzamide derivative. This invention includes a method for preparing the compound and a pharmaceutical composition that utilizes it as an active ingredient for the prevention or treatment of cancer. The derivative has shown the ability to significantly inhibit the proliferation of cancer cells by targeting kinases, particularly Bcr-Abl kinase or Bcr-Abl (T315I) kinase. This makes it a promising candidate for cancer therapy.

Career Highlights

Throughout his career, Kiho Chang has been associated with several organizations that focus on medical innovation. He has worked with the Daegu-Gyeongbuk Medical Innovation Foundation and Immunoforge Co., Ltd. These experiences have allowed him to contribute to advancements in medical research and pharmaceutical development.

Collaborations

Kiho Chang has collaborated with notable colleagues, including Doohyun Lee and Seungyeon Lee. Their joint efforts have furthered research in the field of cancer treatment and have led to significant advancements in pharmaceutical applications.

Conclusion

Kiho Chang's innovative work in developing cancer treatment methods highlights his importance in the pharmaceutical industry. His contributions, particularly through his patented compound, demonstrate the potential for new therapies in combating cancer.